In this article, we will look at the 13 Best 52-Week Low Stocks to Invest In.
On January 27, Sherry Paul, a senior portfolio manager at Morgan Stanley, appeared on a CNBC Television interview to discuss the state of the markets and concerns about volatility. The US stock market is currently undergoing a volatile phase, with narratives such as the “sell America trade,” surging gold prices, and a weaker dollar. Sherry Paul noted that the recent meeting at Davos revealed that the need to rebuild global supply chains, build new partnerships, and advance AI to industries is more urgent than ever. Paul noted that these circumstances suggest that there lies more volatility ahead. However, she highlighted that volatility is part of investing and does not mean anything bad is happening in the market. In fact, she highlighted that this means that something is emerging in the market.
She elaborated that currently, the market is transitioning away from the “Mag 7” to other stocks, which Paul calls the “Magnificent Thematics.” Paul highlighted that investors need to follow these new emerging themes of AI automation in various industries to decide and select sectors they need to be overweight on for greater returns.
With that, let’s take a look at the 13 Best 52-Week Low Stocks to Invest In.
Stocks chart
Our Methodology
To curate the list of 13 Best 52-Week Low Stocks to Invest In, we used the Finviz Stock Screener, Yahoo Finance, and Insider Monkey’s Q3 2025 database. Using the screener, we aggregated a list of stocks trading within 0% to 3% of their 52-week lows. Next, we cross-checked the stock price and 52-week range from Yahoo Finance. Lastly, we ranked the stocks in ascending order of the number of hedge fund holders sourced from Insider Monkey’s database. Please note that the data was recorded on January 29, 2026.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
13 Best 52-Week Low Stocks to Invest In
13. Tradeweb Markets Inc. (NASDAQ:TW)
Price: $103.06
52-Week Range: $101.71 – $152.65
Number of Hedge Fund Holders: 39
Tradeweb Markets Inc. (NASDAQ:TW) is one of the Best 52-Week Low Stocks to Invest In. On January 15, Michael Cyprus from Morgan Stanley reiterated a Hold rating on the stock and lowered the price target from $165 to $162. Earlier, on January 9, Alex Kramm from UBS reiterated a Buy rating on Tradeweb Markets Inc. (NASDAQ:TW) and raised the price target from $135 to $145.
Analysts at Morgan Stanley noted that the reduced price target is based on the company’s December 2025 trading volume release. Tradeweb Markets Inc. (NASDAQ:TW) released its December trading volume report on January 7. The company reached $63.0 trillion in trading volume for the month. Moreover, the average daily volume was $2.8 trillion, reflecting a 27.5% increase from December 2024.
That said, analysts at UBS noted that they acknowledge the recent underperformance, which the firm believes is due to the market share concerns and pricing. However, UBS finds the recent sell-off to be an attractive buying opportunity for investors. This sentiment is driven by the expectation that the company will accelerate its business by the end of 2026. UBS projects a 13% revenue growth for the company in 2026, which it suggests is far ahead of its competitors.
Tradeweb Markets Inc. (NASDAQ:TW) builds and runs electronic trading platforms for financial markets, covering asset classes like rates, credit, equities, and money markets across global regions.
12. Equifax Inc. (NYSE:EFX)
Price: $203.65
52-Week Range: $199.98 – $281.03
Number of Hedge Fund Holders: 43
Equifax Inc. (NYSE:EFX) is one of the Best 52-Week Low Stocks to Invest In. On January 26, Toni Kaplan from Morgan Stanley reiterated a Buy rating on the stock with a $269 price target. Earlier, on January 13, Ashish Sabadra from RBC Capital also reiterated a Buy rating on the stock with a $250 price target.
Analyst Sabadra from RBC Capital sees long-term buying opportunities for credit bureau stocks amidst regulatory concerns. He noted that despite the pressures, fundamentals of the sector remain strong throughout 2026. Sabadra highlighted that Equifax and its peers face short-term stock pressure from regulatory concerns, including the Federal Housing Finance Agency’s shift to bi-merge credit reports, alongside credit card caps, and the Credit Card Competition Act.
Despite these concerns, the firm believes that the companies in the sector could potentially exceed consensus due to strong mortgage inquiries and steady lending. The firm also identified several tailwinds, including those from OBBA, deregulation, lower rates, and modest mortgage recovery. RBC Capital sees Equifax Inc. (NYSE:EFX) to guide 6% to 8% revenue growth in 2026, along with 8% to 11% adjusted EBITDA growth.
Equifax Inc. (NYSE:EFX) is a global data, analytics, and technology company that primarily provides credit reporting, identity management, and workforce verification services.
11. VICI Properties Inc. (NYSE:VICI)
Price: $28.16
52-Week Range: $27.48 – $34.03
Number of Hedge Fund Holders: 44
VICI Properties Inc. (NYSE:VICI) is one of the Best 52-Week Low Stocks to Invest In. VICI Properties Inc. (NYSE:VICI) is trading close to its 52-week lows. However, Wall Street remains bullish on the stock, with 80% of the 25 analysts covering the stock having a Buy rating. The average 12-month price target reflects more than 24% upside from the current levels.
On January 13, Barry Jones from Truist Financials reiterated a Buy rating on the stock with a $38 price target. Earlier, on January 5, Richard Anderson from Cantor Fitzgerald also reiterated a Buy rating on the stock and lowered the price target from $35 to $33.
Analysts at Cantor Fitzgerald noted that the reduced price target is due to the US equity REITs underperforming the S&P 500, with only 2.9% returns in 2025. However, the firm remains optimistic for 2026, driven by a supportive macroeconomic environment and accelerating mergers and acquisitions activity in the sector. The firm noted that stable demand and fundamentals, a strong balance sheet, and a growing dividend yield make the sector attractive despite the underperformance.
VICI Properties Inc. (NYSE:VICI) is a real estate investment trust (REIT) focused on owning gaming, hospitality, wellness, entertainment, and leisure destinations across the US and Canada.
10. Brown & Brown, Inc. (NYSE:BRO)
Price: $72.27
52-Week Range: $71.81 – $125.68
Number of Hedge Fund Holders: 44
Brown & Brown, Inc. (NYSE:BRO) is one of the Best 52-Week Low Stocks to Invest In. On January 28, Michael Zaremski from BMO Capital maintained a Hold rating on the stock and lowered the price target from $88 to $81. On the same day, Yaron Kinar from Mizuho Securities also maintained a Hold rating on Brown & Brown, Inc. (NYSE:BRO) and lowered the price target from $90 to $84.
Zaremski from BMO noted that the company is not as undervalued as it appears when compared to the S&P 500. He noted that while the P/E ratios are at discounted values, the enterprise value to EBITDA and free cash flow yield remain expensive compared to the market.
As a result, the firm reduced its EBITDA estimates for the company by roughly 3% and projected 2.4% organic growth in 2026. Moreover, the firm also fails to see any positive catalysts to drive the stock price higher in the near-term, hence a Hold rating and reduced price target.
Brown & Brown, Inc. (NYSE:BRO) is an insurance brokerage firm that delivers risk management solutions, marketing, and selling property, casualty, and employee benefits insurance products.
9. Ferrari N.V. (NYSE:RACE)
Price: $339.00
52-Week Range: $332.64 – $519.10
Number of Hedge Fund Holders: 46
Ferrari N.V. (NYSE:RACE) is one of the Best 52-Week Low Stocks to Invest In. On January 28, Horst Schneider from Bank of America Securities reiterated a Buy rating on the stock but lowered the price target from $415 to $360. Earlier, on January 25, James Grzinic from Jefferies reiterated a Hold rating on Ferrari N.V. (NYSE:RACE) with a $357.39 price target.
The ratings come ahead of the company’s Q4 2025 earnings, expected to be released on February 10, 2026. Wall Street expects the company to post revenue around $2.11 billion, along with a GAAP EPS of $2.48.
Analysts at BofA noted that they do not expect any major surprises from the company and anticipate a conservative outlook. The firm noted that the reduced price target is based on the assumption that the company will experience a lower average selling price for its vehicles, mainly because Ferrari avoids automatic price hikes just to cover inflation. Moreover, the company has also adjusted its sales mix to reflect more “dilution” from the all-electric Elettra model, which is expected to have lower margins than gas-powered supercars.
The firm sees 2026 as a transitional year for the company. The first half of 2026 is expected to be softer due to production switchovers between models and unfavorable currency swings. However, the second half is expected to lead to higher earnings overall.
Ferrari N.V. (NYSE:RACE), based in Italy but incorporated in the Netherlands, designs, manufactures, and sells luxury sports cars under the iconic Ferrari brand, including models like the F12berlinetta, 488 GTB, and limited-edition one-offs.
8. Paychex, Inc. (NASDAQ:PAYX)
Price: $103.02
52-Week Range: $101.53 – $161.24
Number of Hedge Fund Holders: 53
Paychex, Inc. (NASDAQ:PAYX) is one of the Best 52-Week Low Stocks to Invest In. Paychex, Inc. (NASDAQ:PAYX) is trading close to its 52-week lows. Recently, on January 26, Cantor Fitzgerald initiated the stock with a Sell Rating and a $98 price target. Earlier, on January 16, Charles Nabhan from Stephens reiterated a Hold rating on the stock with a $125 price target.
Analysts at Cantor Fitzgerald noted that they are skeptical of the stock based on the growth challenges faced by the company. The firm highlighted that the company struggles to boost its organic growth due to strong competition in the SMB market and also due to economic headwinds. While the firm acknowledged the recent acquisition of Payco as a strategic step, the benefits of the step towards improving organic growth remain unclear.
The Street has a mixed opinion on Paychex, Inc. (NASDAQ:PAYX) as 14% of the 21 analysts covering the stock have a Buy rating, but 19% analysts maintain a Sell rating. Analysts’ 12-month price target reflects 19% upside from the current level.
Paychex, Inc. (NASDAQ:PAYX) provides integrated human capital management solutions, primarily for small- to medium-sized businesses in the U.S. and parts of Europe.
7. JD.com, Inc. (NASDAQ:JD)
Price: $29.02
52-Week Range: $28.21 – $46.44
Number of Hedge Fund Holders: 55
JD.com, Inc. (NASDAQ:JD) is one of the Best 52-Week Low Stocks to Invest In. On January 26, Joyce Ju from Bank of America Securities reiterated a Buy rating on the stock and lowered the price target from $38 to $36. Earlier, on January 14, Saiyi He from CMB International also reiterated a Buy rating on JD.com, Inc. (NASDAQ:JD) with a $46.8 price target.
The ratings come ahead of the company’s fiscal Q4 2025 earnings expected on March 5, 2026.
Analysts at BofA noted that they expect the company to post a quarterly revenue of roughly RMB356 billion, reflecting 2.6% year-over-year growth. This expectation is broadly in line with the general consensus.
However, the firm expects the company’s direct sales revenue to decline by 3.1% year-over-year, driven by a 13% decline in home appliance and electronics sales. The decline is anticipated to be offset by a mid-teen growth in general merchandise sales. Profitability is also expected to decline 22% year-over-year due to heavy Singles Day subsidies.
Overall, Wall Street is bullish on JD.com, Inc. (NASDAQ:JD), with 88% of the 40 analysts covering the stock having a Buy rating. Analysts’ 12-month price target reflects more than 34% upside from the current level.
JD.com, Inc. (NASDAQ:JD) is China’s leading e-commerce company, operating online retail and marketplaces primarily through its JD Platform. It focuses on direct sales and third-party marketplace services in categories like electronics, appliances, general merchandise, and more, supported by its robust JD Logistics network.
6. Crown Castle Inc. (NYSE:CCI)
Price: $85.81
52-Week Range: $83.21 – $115.76
Number of Hedge Fund Holders: 56
Crown Castle Inc. (NYSE:CCI) is one of the Best 52-Week Low Stocks to Invest In. Crown Castle Inc. (NYSE:CCI) is trading close to its 52-week lows. However, Wall Street has a bullish sentiment on the stock, with analysts’ 12-month price target reflecting more than 24% upside from the current level.
Recently, on January 29, Brandon Nispel from KeyBanc reiterated a Buy rating on the stock with a $115 price target. Earlier, on January 20, Batya Levi from UBS also reiterated a Buy rating on Crown Castle Inc. (NYSE:CCI) but lowered the price target from $127 to $116.
Analyst Levi of UBS noted that she sees a favourable risk/reward profile for the tower stocks in 2026, thus a Buy rating. On the other hand, Brandon Nispel from KeyBanc, who earlier on January 21, reduced the price target on the stock from $120 to $115, released a research note. Nispel highlighted that the lowered price target is based on the company’s announcement regarding DISH Wireless default on its payment applications, leading to the removal of all leasing from the company’s forecasts.
The firm noted that this will result in the omission of around $12 million from its 2026 leasing forecasts and also add a $200 million of churn in 2027 estimates. However, despite the headwind, the firm still calls Crown Castle Inc. (NYSE:CCI) one of its favorite ideas for 2026.
Crown Castle Inc. (NYSE:CCI) owns and operates over 40,000 cell towers and 90,000 route miles of fiber across all major U.S. markets. The company leases space and capacity on this shared communications infrastructure through long-term contracts to wireless carriers and network providers.
5. Atlassian Corporation (NASDAQ:TEAM)
Price: $117.57
52-Week Range: $115.01 – $326.00
Number of Hedge Fund Holders: 60
Atlassian Corporation (NASDAQ:TEAM) is one of the Best 52-Week Low Stocks to Invest In. On January 27, Karl Keirstead from UBS reiterated a Hold rating on the stock and lowered the price target from $185 to $145. Earlier, on January 20, TD Cowen also maintained a Hold rating on the stock and lowered the price target from $205 to $175.
Analysts at TD Cowen noted that the firm is cautiously optimistic on the stock as they see some positive momentum for the business, along with AI risks that could drag growth. The firm highlighted positive factors, including strong momentum in Jira Services, strong progress in cloud migrations, and new packaging options. TD Cowen noted that these factors could help the stock with near-term share price recovery.
However, despite the positive factors, the firm noted that the company shows little traction when it comes to its AI products. These tools are meant to boost efficiency and attract users, but are not yet gaining new adoptions. The firm noted that in the future, AI can automate tasks, reducing the need for paid user seats, thereby raising concerns for the company’s core revenue driver.
Atlassian Corporation (NASDAQ:TEAM) develops team collaboration and productivity software. It offers tools like Jira for project tracking, Confluence for documentation, and others, such as Bitbucket and Loom, all built on a unified cloud platform with AI features.
4. Humana Inc. (NYSE:HUM)
Price: $195.03
52-Week Range: $191.39 – $315.35
Number of Hedge Fund Holders: 60
Humana Inc. (NYSE:HUM) is one of the Best 52-Week Low Stocks to Invest In. Wall Street is bullish on Humana Inc. (NYSE:HUM) ahead of its fiscal Q4 2025 earnings, expected to be released on February 11, 2026. The Street expects the company to post quarterly revenue around $32.08 billion, along with a negative GAAP EPS of $4.08.
Recently, on January 27, David S Macdonald from Truist Financial reiterated a Hold rating on the stock without disclosing any price targets. On the same day, Lance Wilkes from Bernstein reiterated a Buy rating on Humana Inc. (NYSE:HUM) with a $344 price target.
On January 27, Piper Sandler released a research note discussing the impact of Medicare Advantage Advance Notice on healthcare stocks. Medicare Advantage is a private insurance alternative to traditional Medicare, which covers roughly half of the US seniors. The latest notice sets a benchmark for insurers such as Humana Inc, which is expected to directly impact revenue and profit margins.
Moreover, on the same day, Reuters reported that the Trump administration has proposed a much smaller than expected increase in 2027 Medicare Advantage rates. Since the news, the share price of Humana Inc. (NYSE:HUM) has fallen more than 24%, bringing it close to its 52-week lows.
Humana Inc. (NYSE:HUM) is a leading health insurance and well-being company focused on Medicare Advantage plans, Medicaid services, and specialty insurance products for individuals and employer groups.
3. Abbott Laboratories (NYSE:ABT)
Price: $106.17
52-Week Range: $105.27 – $141.23
Number of Hedge Fund Holders: 68
Abbott Laboratories (NYSE:ABT) is one of the Best 52-Week Low Stocks to Invest In. On January 29, Freedom Capital upgraded the stock from Hold to Buy, but lowered the price target from $130 to $120. Earlier, on January 23, UBS reiterated a Buy rating on the stock with a $158 price target.
The positive ratings come despite the company missing revenue estimates for its fiscal Q4 2025 earnings, released on January 22. The company grew its revenue by 4.24% year-over-year to $11.46 billion, but fell short of the consensus by $342.91 million. The EPS of $1.50 topped expectations by $0.01.
The analysts at Freedom Capital noted that the weak results were mainly due to the weakness in the company’s Nutrition segment. The firm noted that management expects this weakness to persist throughout the first half of 2026. However, the Medical Devices and Established Pharma segment of Abbott Laboratories (NYSE:ABT) continues to be the key driver of growth and is offsetting challenges in other segments.
Freedom Capital remains optimistic on the company’s future growth prospects, driven by the integration of Exact Sciences in Q2. The firm finds the company’s 6.5% to 7.5% organic revenue growth guidance for 2026 to be conservative.
Abbott Laboratories (NYSE:ABT) is a global healthcare company with a broad portfolio spanning diagnostics, medical devices, nutrition, and branded generic medicines.
2. Flutter Entertainment plc (NYSE:FLUT)
Price: $168.78
52-Week Range: $166.21 – $313.68
Number of Hedge Fund Holders: 95
Flutter Entertainment plc (NYSE:FLUT) is one of the Best 52-Week Low Stocks to Invest In. On January 29, Jed Kelly from Oppenheimer reiterated a Buy rating on the stock but lowered the price target from $320 to $280. Earlier, on January 22, Jordan Bender from Citizens JPM also reiterated a Buy rating on Flutter Entertainment plc (NYSE:FLUT) but lowered the price target from $313 to $275.
Analysts at Citizens noted that the reduced price target is based on the company’s December 2025 performance, which the firm finds bad, considering the company’s long history as a top operator. The firm highlighted that data shows that the company posted fairly decent gaming margins in November 2025 and December 2025. However, these figures failed to overcome the sluggish October results. Moreover, the same store’s December handle also fell to low double digits.
Overall, Wall Street maintains a bullish sentiment on Flutter Entertainment plc (NYSE:FLUT) with analysts’ 12-month price target reflecting more than 67% upside from the current level.
Flutter Entertainment plc (NYSE:FLUT) operates as a leading online sports betting and iGaming company, serving customers worldwide through brands like Paddy Power, Betfair, PokerStars, and Sportsbet.
1. Netflix, Inc. (NASDAQ:NFLX)
Price: $82.61
52-Week Range: $81.93 – $134.12
Number of Hedge Fund Holders: 154
Netflix, Inc. (NASDAQ:NFLX) is one of the Best 52-Week Low Stocks to Invest In. On January 30, Laurent Yoon from Bernstein reiterated a Buy rating on the stock with a $115 price target. Earlier, on January 27, Freedom Capital Market upgraded Netflix, Inc. (NASDAQ:NFLX) from Hold to Buy with a $104 price target.
The ratings follow the company’s fiscal Q4 2025 earnings release announced on January 20. The company grew its revenue by 17.61% year-over-year to $12.05 billion, ahead of the consensus by $83.91 million. The EPS of $0.56 also topped the estimates by $0.01.
Analysts at Freedom Capital noted that Netflix, Inc. (NASDAQ:NFLX) posted strong growth in its subscriber base and in its advertising business, which drove the quarter to beat expectations. Moreover, the company also met a key milestone and reached 325 million paid subscribers during fiscal Q4 2025.
Despite the positive results, the firm noted that Netflix provided conservative guidance for Q1 and fiscal 2026. This guidance falls below Freedom Capital’s expectations. In addition, the firm also expects the company to face higher operating costs due to the Warner Bros acquisition.
Netflix, Inc. (NASDAQ:NFLX) is a global streaming entertainment company offering on-demand movies, TV series, and original content to subscribers worldwide.
While we acknowledge the potential of NFLX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NFLX and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
